Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China
· Delayed Price · Currency is CNY 7.87
-0.02 (-0.25%)
Apr 30, 2026, 9:55 AM CST
SHE:300942 Market Cap
SHE:300942 has a market cap or net worth of 3.20 billion as of April 29, 2026. Its market cap has decreased by -12.58% in one year.
Market Cap
3.20B
Enterprise Value
3.06B
Revenue
271.53M
Ranking
n/a
PE Ratio
467.94
Stock Price
7.87
Market Cap Chart
Since February 9, 2021, SHE:300942's market cap has decreased from 14.45B to 3.20B, a decrease of -77.88%. That is a compound annual growth rate of -25.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 3.20B | -16.15% |
| Dec 31, 2025 | 3.81B | 10.95% |
| Dec 31, 2024 | 3.44B | -26.69% |
| Dec 29, 2023 | 4.69B | -31.80% |
| Dec 30, 2022 | 6.87B | -40.61% |
| Dec 31, 2021 | 11.57B | -19.92% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Landfar Bio-medicine | 3.23B |
| Shanghai Model Organisms Center | 3.11B |
| Yantai Zhenghai Biotechnology | 3.33B |
| Novoprotein Scientific | 3.35B |
| Jiangsu Sihuan Bioengineering | 3.02B |
| Guangdong VTR Bio-Tech | 2.97B |
| Beijing Kawin Technology Share-Holding | 3.46B |
| Shanghai Shen Lian Biomedical | 3.56B |